Country: Australia
Bahasa: Inggeris
Sumber: Department of Health (Therapeutic Goods Administration)
Ciclesonide
Takeda Pharmaceuticals Australia Pty Ltd
Medicine Registered
OMNARIS CMI AU Version 3_ _ Page 1 _ _ _ _ OMNARIS ® NASAL SPRAY (om-NAR-is) _ciclesonide (si-KLESS-oh-nide) _ CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Omnaris. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in this leaflet was last updated on the date listed on the final page. More recent information on the medicine may be available. You should ensure that you speak to your pharmacist or doctor to obtain the most up to date information on this medicine. You can also download the most up to date leaflet from http://www.takedaaustralia.com.au. Those updates may contain important information about the medicine and its use of which you should be aware. All medicines have risks and benefits. Your doctor has weighed the risks of you using this medicine against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT OMNARIS IS USED FOR The medicine is sprayed into the nose to help treat symptoms of seasonal allergic rhinitis in adults and children 6 years of age and older, and perennial allergic rhinitis in adults and adolescents 12 years of age and older. Allergic rhinitis (hay fever) is an inflammation or swelling of the nose lining, which may cause blockage, runny nose, itching and/or sneezing. You may have symptoms only during spring or summer (seasonal). This type of allergy is generally due to various pollens. Some people may experience symptoms all year round (perennial). This is usually caused by h Baca dokumen lengkap
_OMNARIS_ _®_ _ PI _ _V3.0 _ _Page 1 of 11 _ OMNARIS ® NASAL SPRAY PRODUCT INFORMATION NAME OF THE MEDICINE Active ingredient: Ciclesonide Chemical name (CAS): pregna-1,4-diene-3,20-dione,16,17-[[R-cyclohexylmethylene] bis(oxy)]-11-hydroxy-21-(2-methyl-1- oxopropoxy)- ,(11β,16α)-. Molecular formula: C 32 H 44 O 7 CAS Number: 126544-47-6 (as the R-epimer). Molecular weight: 540.7 Structural formula: DESCRIPTION Ciclesonide is a white to yellow-white powder, practically insoluble in water and freely soluble in ethanol and acetone. OMNARIS Nasal Spray is a metered-dose, manual-pump spray formulation containing a hypotonic aqueous suspension of ciclesonide. OMNARIS Nasal Spray also contains cellulose- microcrystalline, carmellose sodium, hypromellose, potassium sorbate, disodium edetate, hydrochloric acid to adjust the pH to 4.5, and purified water. The contents of one 15 mL or 10 mL bottle provide 120 actuations or 60 actuations, respectively, after initial priming (see ‘DOSAGE AND ADMINISTRATION’). Once primed, each actuation of the pump delivers 50 µg ciclesonide in a volume of 70 µL from the nasal actuator. PHARMACOLOGY MECHANISM OF ACTION Ciclesonide is a pro-drug that is enzymatically hydrolysed to a pharmacologically active metabolite, C21-desisobutyryl-ciclesonide (des-ciclesonide) following intranasal application. Des-ciclesonide has anti-inflammatory activity with affinity for the glucocorticoid receptor that is 120 times higher than the parent compound. The precise mechanism through which ciclesonide affects allergic rhinitis symptoms is not known. Corticosteroids have been shown to have a wide range of effects on multiple cell types (e.g., mast cells, eosinophils, neutrophils, macrophages, and lymphocytes) and mediators Baca dokumen lengkap